🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of this study is to determine if sapanisertib in combin...
Status
Completed
Location
University of Alabama Comprehensive Cancer Center
Start Date
2016-04-01
Trial ID
NCT02725268
Treatments Being Tested
This study evaluates efficacy of TAK- 228 and TAK- 117 followed by cisplati...
Status
Completed
Location
Baylor University Medical Center
Start Date
2017-07-18
Trial ID
NCT03193853
Treatments Being Tested
The purpose of this study is to evaluate the relative bioavailability of a ...
Status
Completed
Location
Multiple Locations
Start Date
2016-01-08
Trial ID
NCT02625259
Treatments Being Tested
The purpose of this study was to evaluate the safety and to determine dose-...
Status
Completed
Location
Multiple Locations
Start Date
2013-06-28
Trial ID
NCT01899053
This is a Phase 2, multicenter, open-label, single-arm study to evaluate th...
Status
Recruiting
Location
UC San Diego Moores Cancer Center
Start Date
2024-12-12
Trial ID
NCT06463028
Treatments Being Tested
This study will evaluate the feasibility of optimizing the safety and toler...
Status
Terminated
Location
University of Alabama
Start Date
2022-04-22
Trial ID
NCT05300048
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of single-...
Status
Completed
Location
USC Norris Comprehensive Cancer Center
Start Date
2016-06-30
Trial ID
NCT02724020
Treatments Being Tested
The study is a Phase 1b/2, multi-center, open-label, dose escalation trial ...
Status
Recruiting
Location
START Los Angeles
Start Date
2026-04-22
Trial ID
NCT07558733
Treatments Being Tested
The purpose of this study is to determine the recommended phase 2 dose (RP2...
Status
Terminated
Location
Multiple Locations
Start Date
2015-06-03
Trial ID
NCT02393209
The purpose of this study is to determine the maximum tolerated dose (MTD) ...
Status
Completed
Location
Multiple Locations
Start Date
2011-10
Trial ID
NCT01449370
Treatments Being Tested